News

The National Interest on MSN8dOpinion
Trump Should Not Abandon March-In Rights
Moving forward with the Biden administration’s guidance could deliver lower drug prices and allow more Americans to reap the ...
For years, North Korea has been secretly placing young IT workers inside Western companies. With AI, their schemes are now ...
Between the fellowship application and scientific review process, she had spent a year of ... and has a recent history of ...
Former vice president Kamala Harris has mercilessly rebuked President Donald Trump in her first extensive remarks since ...
Four years after the end of a first term marked by furor, folly, and a failed insurrection, Donald Trump is returning to the ...
Colossal, a genetics startup, has birthed three pups that contain ancient DNA retrieved from the remains of the animal’s ...
The auction value of the seized assets from the corruption case of Asuransi Jiwasraya is allegedly below the market price. It ...
Gideon Rachman Hello, and welcome to the Rachman Review. I’m Gideon Rachman, chief foreign affairs commentator of the Financial Times. This week’s podcast is about El Salvador and its controversial ...
Robert F. Kennedy Jr., the U.S. Health and Human Services secretary, and Marty Makary, the new Food and Drug Administration ...
Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing (OSD) is no exception. Often when transitioning molecules from phase I to II, ...
Spanios and White Lion Capital LLC are encouraging oncology companies to capitalize on these regulatory and policy advances for innovative drug development. Traditional preclinical animal models ...
models for robust preclinical validation while accessing innovative funding from White Lion Capital LLC to advance their clinical development. Through this partnership, companies that engage ...